MedCity News February 19, 2024
Marissa Plescia

HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA.

This month, the U.S. Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) took steps to expand access to opioid use disorder treatment through its new final rule, which includes a provision that permanently allows for the initiation of treatment (methadone and buprenorphine) via telehealth. However, the final rule narrowly applies to only practitioners working in Opioid Treatment Programs (OTPs) and does not include other providers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, HHS, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
End of home health, telehealth coverage threatens hospitals' recovery: Fitch
Election Implications for Telehealth, Health Equity, AI and Life Sciences

Share This Article